Psychiatry

Publications

Bennett, MH; Poweleit, EA; Vaughn, SE; Retke, B; Toren, P; Strawn, JR; Ramsey, LB. Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles. Clinical and Translational Science. 2026; 19(3):e70525.

Blackburn, AD; Mckinney, W; Birnschein, AM; Esbensen, AJ; Mckinley, S; Rosselot, H; Hoffman, EK; Erickson, C; Shaffer, R. Adapting a Behavioral Intervention for Caregivers of Children with Down Syndrome or Fragile X Syndrome: A Pilot Study of RUBI-DD. Behavioral Sciences. 2026; 16(3).

Cho, W; Kobayashi, M; Kambara, H; Tanaka, H; Kagawa, T; Sato, M; Kim, H; Miyakoshi, M; Makeig, S; Iversen, JR; Yoshimura, N. Decomposing Juggling Skill into Sequencing, Prediction, and Accuracy: A Computational Model with Low-Gravity VR Training. Sensors. 2026; 26(1).

Dakopolos, A; Vilay, N; Chen, I; Kaat, AJ; Condy, E; Coleman, J; Berry-Kravis, E; Erickson, C; Thurm, A; Hessl, D. Clinical Relevance of NIH Toolbox Cognition Battery Developmental Change in Intellectual and Developmental Disabilities: Associations with Verbal Reasoning. American Journal on Intellectual and Developmental Disabilities. 2026; ahead-of-print(ahead-of-print):1-7.

De Stefano, LA; Kim, H; Erickson, CA; Pedapati, EV; Dominick, KC; Shaffer, R; Wink, LK; Schmitt, LM; Miyakoshi, M. Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. Scientific Reports. 2026; 16(1).

De Stefano, LA; Kim, H; Erickson, CA; Schmitt, LM; Dominick, KC; Pedapati, EV; Huckle, R; Wilson, R; Mckinney, WS; Reisinger, DL; Nelson, MN; Dapore, AE; Horn, PS; Miyakoshi, M. Gaboxadol increases resting theta and alpha power without affecting evoked responses in fragile X syndrome in a home-based setting. Journal of Neurodevelopmental Disorders. 2026.

Elmaghraby, R. Editorial: Physical Activity and Depression in Youth: Insights From a Longitudinal Birth Cohort Study. Journal of the American Academy of Child and Adolescent Psychiatry. 2026; 65(2):158-160.

Elmaghraby, R; Patel, F; Brown, H; Gorenstein, M; Bain, J; Grinspan, ZM; Pedapati, E; Veenstra-Vanderweele, J; Vandana, P. Novel therapeutics in autism spectrum disorder. Neurotherapeutics. 2026; 23(1):e00857.

Kim, H; Miyakoshi, M; Kambara, H; Yoshimura, N; Makeig, S; Iversen, JR. Three-ball cascade juggling as a paradigm to study complex motor task execution using mobile brain-body imaging (EEG). Proceedings of the Royal Society of London. Biological Sciences. 2026; 293(2066).

Kornfeld-Sylla, SS; Gelegen, C; Norris, JE; Chaloner, FA; Lee, M; Khela, M; Heinrich, MJ; Finnie, PSB; Ethridge, LE; Erickson, CA; Schmitt, LM; Cooke, SF; Wilkinson, CL; Bear, MF. A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice. Nature Communications. 2026; 17(1):1497.

Lehmann, T; Miyakoshi, M; Baumeister, J. Conceptual rethinking of whole-body perturbation-evoked potentials as a biomarker of extralemniscal sensory transmission, alertness and arousal. Frontiers in Human Neuroscience. 2026; 20:1825052.

Liu, Y; Siekierski, P; De Stefano, LA; Westerkamp, G; Ethridge, L; Blank, E; Miyakoshi, M; Thorpe, RV; Jones, SR; Erickson, C; Horn, PS; Pedapati, EV. Elevated gamma spectral event peak power during auditory chirp is associated with neuropsychiatric features in Fragile X syndrome. Clinical Neurophysiology. 2026; 185:2111713.

Mostaghimi, S; Pinto-Orellana, MA; Green, N; Shrey, DW; Miyakoshi, M; Hussain, SA; Lopour, BA. Prediction of treatment response in infantile epileptic spasms syndrome using EEG phase-amplitude coupling. Epilepsia Open. 2026; 11(3):801-813.

Nelson, MA; Schmitt, LM; Horn, PS; Berry-Kravis, E; Hessl, D; Shaffer, RC; Carpenter, R; Budimirovic, DB; Wang, P; Reisinger, DL; Walton-Bowen, K; Erickson, CA. Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds. Journal of Autism and Developmental Disorders. 2026; 56(4):1658-1670.

Pedapati, EV; Vanderklish, PW; Sarraf, ST; Gargosky, S; Nelson, M; Richter, S; Westerkamp, G; Erickson, CA. SPG601-associated modulation of resting-state EEG and improvement in executive function in a fragile X syndrome randomized controlled crossover study. Scientific Reports. 2026; 16(1).

Shillington, A; White, L; Doberstein, R; Hopkin, RJ; Zappia, K; Harris, K; Lamy, M. Conferring a Genetic Diagnosis for Children with Neurodevelopmental Disorders in the Inpatient Psychiatry Setting May Reduce Hospital Stays and Improve Behavior. Advances in Neurodevelopmental Disorders. 2026; 10(2):241-255.

Simpson, S; Dominick, KC; Erickson, CA; Lamy, M. Safety and Efficacy of Paliperidone Palmitate in Pediatric Patients with Autism and Intellectual Disability. Journal of Autism and Developmental Disorders. 2026; 56(5):2077-2083.

Trelles, P; Levy, T; Jain, S; Lerman, B; Friedman, K; Chung, WK; Dominick, KC; Dunham-Carr, K; Lamy, M; Levin, AR; Smith, JR; Srivastava, S; Thurm, A; Siegel, M. Catatonia in Autism and Neurodevelopmental Disorders: A Scoping Review for Advancing Identification, Practice, and Research. Journal of the American Academy of Child and Adolescent Psychiatry. 2026.